HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Active leprosy treated effectively with ofloxacin.

AbstractThe patient is a 25-year-old Filipino who showed polymorphous eruptions over the whole body, right ulnar nerve paresis, polyneuropathy and hypalgesia in the area of eruptions. Because the biopsy specimen showed foam cells, histiocytes, epithelioid cells, many Mycobacterium leprae and no giant cells, the diagnosis of borderline-lepromatous (BL) type was made. The symptoms were improved by the administration of 300 mg/day ofloxacin. Because the monotherapy using ofloxacin has been reported to be effective in all 5 previously reported cases of BL type leprosy, it may be recommended for a larger number of leprosy cases.
AuthorsY Mochizuki, M Oishi, C Nishiyama, T Iida (Affiliation: Department of Neurology, Nihon University School of Medicine, Tokyo.)
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 35 Issue 9 Pg. 749-51 (Sep 1996) ISSN: 0918-2918 [Print] JAPAN
PMID8915706 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Infective Agents
  • Ofloxacin
Topics
  • Adult
  • Anti-Infective Agents (therapeutic use)
  • Biopsy
  • Humans
  • Leprosy (drug therapy, pathology)
  • Male
  • Ofloxacin (therapeutic use)
  • Skin (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD